Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raquel Largo

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Nature Reviews. Rheumatology|August 18, 2017
Osteoarthritis: Chondroitin sulfate - CONCEPT clear, uncertainties unchangedGabriel Herrero-Beaumont, Raquel Largo
Annals of the Rheumatic Diseases|January 28, 2021
Response to: 'Correspondence on "Glucosamine and O-GlcNAcylation: a novel immunometabolic therapeutic target for OA and chronic, low-grade systemic inflammation?' by Angelides and ManoliosGabriel Herrero-Beaumont, Raquel Largo
Annals of the Rheumatic Diseases|June 20, 2020
Glucosamine and O-GlcNAcylation: a novel immunometabolic therapeutic target for OA and chronic, low-grade systemic inflammation?Gabriel Herrero-Beaumont, Raquel Largo
Arthritis and Rheumatism|February 2, 2008
Does oral glucosamine prevent subchondral bone loss in an animal model of osteoarthritis? Comment on the article by Wang et alSantos Castañeda, Raquel Largo, Emilio Calvo, et al.
International Journal of Molecular Sciences|October 19, 2013
Lipid transport and metabolism in healthy and osteoarthritic cartilageAmanda Villalvilla, Rodolfo Gómez, Raquel Largo, et al.
Biochemical Pharmacology|December 30, 2015
Oxidative stress, autophagy, epigenetic changes and regulation by miRNAs as potential therapeutic targets in osteoarthritisSergio Portal-Núñez, Pedro Esbrit, María José Alcaraz, et al.
Nature Reviews. Rheumatology|December 17, 2014
TLR4 signalling in osteoarthritis--finding targets for candidate DMOADsRodolfo Gómez, Amanda Villalvilla, Raquel Largo, et al.
Rheumatology (Oxford, England)|July 17, 2023
Lights and shadows on the efficacy of tocilizumab monotherapy in large vessel giant cell arteritisMiguel Ángel González-Gay, Santos Castañeda, Elena Heras-Recuero, et al.
Rheumatology (Oxford, England)|July 24, 2013
Osteoarthritis: a progressive disease with changing phenotypesSantos Castañeda, Jorge A Roman-Blas, Raquel Largo, et al.
Biochemical Pharmacology|October 4, 2011
Subchondral bone as a key target for osteoarthritis treatmentSantos Castañeda, Jorge A Roman-Blas, Raquel Largo, et al.
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Nature Reviews. Rheumatology|August 18, 2017
Osteoarthritis: Chondroitin sulfate - CONCEPT clear, uncertainties unchangedGabriel Herrero-Beaumont, Raquel Largo
Annals of the Rheumatic Diseases|January 28, 2021
Response to: 'Correspondence on "Glucosamine and O-GlcNAcylation: a novel immunometabolic therapeutic target for OA and chronic, low-grade systemic inflammation?' by Angelides and ManoliosGabriel Herrero-Beaumont, Raquel Largo
Annals of the Rheumatic Diseases|June 20, 2020
Glucosamine and O-GlcNAcylation: a novel immunometabolic therapeutic target for OA and chronic, low-grade systemic inflammation?Gabriel Herrero-Beaumont, Raquel Largo
Arthritis and Rheumatism|February 2, 2008
Does oral glucosamine prevent subchondral bone loss in an animal model of osteoarthritis? Comment on the article by Wang et alSantos Castañeda, Raquel Largo, Emilio Calvo, et al.
International Journal of Molecular Sciences|October 19, 2013
Lipid transport and metabolism in healthy and osteoarthritic cartilageAmanda Villalvilla, Rodolfo Gómez, Raquel Largo, et al.
Biochemical Pharmacology|December 30, 2015
Oxidative stress, autophagy, epigenetic changes and regulation by miRNAs as potential therapeutic targets in osteoarthritisSergio Portal-Núñez, Pedro Esbrit, María José Alcaraz, et al.
Nature Reviews. Rheumatology|December 17, 2014
TLR4 signalling in osteoarthritis--finding targets for candidate DMOADsRodolfo Gómez, Amanda Villalvilla, Raquel Largo, et al.
Rheumatology (Oxford, England)|July 17, 2023
Lights and shadows on the efficacy of tocilizumab monotherapy in large vessel giant cell arteritisMiguel Ángel González-Gay, Santos Castañeda, Elena Heras-Recuero, et al.
Rheumatology (Oxford, England)|July 24, 2013
Osteoarthritis: a progressive disease with changing phenotypesSantos Castañeda, Jorge A Roman-Blas, Raquel Largo, et al.
Biochemical Pharmacology|October 4, 2011
Subchondral bone as a key target for osteoarthritis treatmentSantos Castañeda, Jorge A Roman-Blas, Raquel Largo, et al.
Pageof 11